CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro

被引:72
作者
Salkowitz, JR
Bruse, SE
Meyerson, H
Valdez, H
Mosier, DE
Harding, CV
Zimmerman, PA
Lederman, MM
机构
[1] Case Western Reserve Univ, Sch Med, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, AIDS Res Ctr, Sch Med, Dept Med,Div Infect Dis, Cleveland, OH 44106 USA
[3] Univ Hosp Cleveland, Dept Pathol, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Cleveland, OH 44106 USA
[5] Univ Hosp Cleveland, Ctr AIDS Res, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA
[6] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[7] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA
关键词
D O I
10.1016/S1521-6616(03)00147-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The common CCR5 promoter polymorphism at position -2459 (A/G) has been associated with differences in the rate of progression to AIDS, where HIV-1-infected individuals with the CCR5-2459 G/G genotype exhibit slower disease progression than those with the A/A genotype. Mechanisms underlying the relationship between these polymorphisms and disease progression are not known. Here through in vitro infection of peripheral blood mononuclear cells obtained from healthy Caucasian blood donors with macrophage-tropic HIV-1 isolates we observed low, medium, and high viral propagation in association with G/G, A/G, and A/A promoter genotypes, respectively. Flow cytometric analysis of unstimulated CD14+ monocytes from these same donors revealed a similar hierarchy of CCR5 receptor density in association with promoter genotypes. Finally, PBMC from persons with the G/G promoter polymorphism produced higher levels of P-chemokines after in vitro stimulation. Thus, the CCR5 -2459 (A/G) promoter polymorphism determines CCR5 expression and predicts the magnitude of HIV-1 propagation in vitro. These findings may provide important insight regarding the regulation of mechanisms that influence the rate of HIV-1 propagation and progression to AIDS. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:234 / 240
页数:7
相关论文
共 33 条
[1]  
Akhatib G., 1996, SCIENCE, V272, P1955
[2]   Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans [J].
An, P ;
Martin, MP ;
Nelson, GW ;
Carrington, M ;
Smith, MW ;
Gong, K ;
Vlahov, D ;
O'Brien, SJ ;
Winkler, CA .
AIDS, 2000, 14 (14) :2117-2122
[3]   The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes [J].
Bleul, CC ;
Wu, LJ ;
Hoxie, JA ;
Springer, TA ;
Mackay, CR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1925-1930
[4]   CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors [J].
Clegg, AO ;
Ashton, LJ ;
Biti, RA ;
Badhwar, P ;
Williamson, P ;
Kaldor, JM ;
Stewart, GJ .
AIDS, 2000, 14 (02) :103-108
[5]   IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J].
COCCHI, F ;
DEVICO, AL ;
GARZINODEMO, A ;
ARYA, SK ;
GALLO, RC ;
LUSSO, P .
SCIENCE, 1995, 270 (5243) :1811-1815
[6]   Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene [J].
Dean, M ;
Carrington, M ;
Winkler, C ;
Huttley, GA ;
Smith, MW ;
Allikmets, R ;
Goedert, JJ ;
Buchbinder, SP ;
Vittinghoff, E ;
Gomperts, E ;
Donfield, S ;
Vlahov, D ;
Kaslow, R ;
Saah, A ;
Rinaldo, C ;
Detels, R ;
OBrien, SJ .
SCIENCE, 1996, 273 (5283) :1856-1862
[7]  
*DHHS, 1997, DIV AIDS NIAID DIAID, P46
[8]   Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes [J].
Gonzalez, E ;
Bamshad, M ;
Sato, N ;
Mummidi, S ;
Dhanda, R ;
Catano, G ;
Cabrera, S ;
McBride, M ;
Cao, XH ;
Merrill, G ;
O'Connell, P ;
Bowden, DW ;
Freedman, BI ;
Anderson, SA ;
Walter, EA ;
Evans, JS ;
Stephan, KT ;
Clark, RA ;
Tyagi, S ;
Ahuja, SS ;
Dolan, MJ ;
Ahuja, SK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (21) :12004-12009
[9]  
HUANG Y, 1996, NAT MED, V2
[10]   Effects of CCR5-Δ32, CCR2-641, and SDF-1 3′A alleles on HIV-1 disease progression:: An international meta-analysis of individual-patient data [J].
Ioannidis, JPA ;
Rosenberg, PS ;
Goedert, JJ ;
Ashton, LJ ;
Benfield, TL ;
Buchbinder, SP ;
Coutinho, RA ;
Eugen-Olsen, J ;
Gallart, T ;
Katzenstein, TL ;
Kostrikis, LG ;
Kuipers, H ;
Louie, LG ;
Mallal, SA ;
Margolick, JB ;
Martinez, OP ;
Meyer, L ;
Michael, NL ;
Operskalski, E ;
Pantaleo, G ;
Rizzardi, GP ;
Schuitemaker, H ;
Sheppard, HW ;
Stewart, GJ ;
Theodorou, ID ;
Ullum, H ;
Vicenzi, E ;
Vlahov, D ;
Wilkinson, D ;
Workman, C ;
Zagury, JF ;
O'Brien, TR .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (09) :782-795